Report #2871796

Received Nov 10, 2025

ER / ED visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 50 yrs
State: SC
Recovered: Not recovered
Vaccinated: Nov 2, 2025
Onset: Nov 2, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	X5T42	SC / LA

Symptoms (6)

Incorrect route of product administrationInjection site bruisingInjection site erythemaInjection site painInjection site pruritusInjection site swelling

Symptom narrative

Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient received the 2nd dose of Shingrix on 11/2/25; administered by Rph on duty; Patient presented to pharmacy 11/3/25 to speak with PIC; Patient presented a picture showing the back of the left arm red and swollen; Patient stated that when she questioned the site of administration, RPh stated that it was to be given subcutaneously, and previous administration was done incorrectly; However, PIC showed patient on the box where it states to be given "intramuscularly only".